about
Comparative effects of glyceryl trinitrate and amyl nitrite on pulse wave reflection and augmentation index.Derivatization of estrogens enhances specificity and sensitivity of analysis of human plasma and serum by liquid chromatography tandem mass spectrometry.Aromatase Inhibition Reduces Insulin Sensitivity in Healthy MenRisk of death following admission to a UK hospital with diabetic ketoacidosis.Androgen deficiency and type 2 diabetes mellitus.Adrenal insufficiency in patients on long-term opioid analgesia.Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.Fatal haemorrhage following fine needle aspiration of the thyroid.The prevalence of structural pituitary abnormalities by MRI scanning in men presenting with isolated hypogonadotrophic hypogonadism.Flash Glucose Monitoring Improves Outcomes in a Type 1 Diabetes Clinic.Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosisPresentation, diagnostic assessment and surgical outcomes in primary hyperparathyroidism: a single centre's experienceDifferentiated thyroid cancer: A retrospective evaluation of the impact of changes to disease management guidelines on patients in South East ScotlandPreserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetesFlash Glucose Monitoring is associated with improved glycaemic control but use is largely limited to more affluent people in a UK diabetes centreThe effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in ScotlandValidated criteria for the interpretation of a single measurement of serum cortisol in the investigation of suspected adrenal insufficiencyMarked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes
P50
Q35826812-746D751C-4EEC-43C3-8117-F5438BD64193Q36685794-EC5CCAFC-024E-48C4-A3E8-6AE4B04A2C8FQ36911503-8220FE0D-D6D8-4123-A62D-C3A29500EC10Q37242951-326DC1BE-B893-4A81-BCE9-AAC1855E80A0Q38207385-428F5E42-E4C2-444B-A3EE-D57086A154FEQ44337731-00DF0966-63D1-45DE-BFA1-04488AE9D060Q47777865-F0CD6B97-44D0-47EA-805F-25E4B152F909Q47918861-3746A3AD-873D-45C5-B99F-714E6B1FE2D2Q49047504-DFF6ACD4-0E20-48FB-B257-276510300AFDQ50351251-2965ACFD-F121-44A2-83CD-2CFE0748E0B2Q57020424-6A926EB7-352E-4299-8861-5D7CDE8F22C1Q58716642-A791B141-83B8-4702-8868-8FFBEE3ECD2AQ89046417-CCEF9C6B-456A-4303-B4F2-A2D8D02C988EQ89603615-457B989D-5412-4914-A183-2A0A1FE31457Q89913223-D11FA193-F9F7-4EE6-B133-329ECD97F6ECQ92225516-9BDD72DB-A724-4BDA-AB6E-9C8E78AEC34BQ92411209-481E075B-40E4-41CE-8D28-9D6624706991Q92608863-A1DD2484-586B-4572-9654-FA9C23B036A3
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Fraser W Gibb
@ast
Fraser W Gibb
@en
Fraser W Gibb
@es
Fraser W Gibb
@nl
type
label
Fraser W Gibb
@ast
Fraser W Gibb
@en
Fraser W Gibb
@es
Fraser W Gibb
@nl
altLabel
Fraser Gibb
@en
prefLabel
Fraser W Gibb
@ast
Fraser W Gibb
@en
Fraser W Gibb
@es
Fraser W Gibb
@nl
P106
P31
P496
0000-0002-5576-6463